Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Shape Robotics changes certified adviser

Company Announcement No. 21-2021Copenhagen, March 22, 2021 Shape Robotics has engaged Norden CEF as new certified adviser, effective from April 1st 2021. “We are pleased to start working with Norden CEF as our new certified adviser. Their experienced team and large network will support our continued growth journey as well as help us meet the regulatory obligations at Nasdaq First North” says David Johan Christensen, CEO. Norden CEF has assisted several companies on Nasdaq First North Growth Market. John Norden is certified advisor for Alefarm Brewing, FOM Technologies, Dataproces

Isofol receives notice that Clinical Use Patent in Europe for Drug Candidate arfolitixorin will be approved

GOTHENBURG, Sweden, March 22, 2021 – Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), today announced that a notice that a Clinical Use Patent for the drug candidate arfolitixorin will be approved in Europe. The patent covers a dose regimen for treating solid tumors, such as colorectal, stomach, breast and liver cancer and expires in 2038.The patent application that will be granted , EP18150457.2, includes a dose regimen involving two or more injections of arfolitixorin in combination with 5-fluorouracil (5-FU). These two agents may also be given in combination

NOTICE TO THE ANNUAL GENERAL MEETING OF HEXPOL AB (publ)

Shareholders of HEXPOL AB are hereby given notice of the Annual General Meeting (AGM) to be held on Wednesday, 28 April 2021. Due to the continued spread of the coronavirus and the authorities’ regulations and advice on avoiding public gatherings, the Board has decided that the AGM will be held without physical presence of shareholders, proxy holders and third parties and that the shareholders are able to exercise their voting rights in advance, only by postal voting before the general meeting. Information on the resolutions passed at the AGM will be disclosed on 28 April 2021, as soon as

EQL Pharma's Mellozzan (melatonin) tablets now available from pharmacies in Sweden

Lund, March 22, 2021. EQL Pharma today announces that the company's Mellozzan (melatonin in tablet form) is now available in pharmacies in Sweden. Mellozzan, which is a prescription-only drug and used for treating insomnia in children with ADHD where other so-called sleep hygiene measures have been insufficient, is available at doses of 1 mg, 2 mg, 3 mg, 4 mg and 5 mg. Mellozzan is also used as a short-term treatment for jet lag in adults."We are pleased that Mellozzan is now available in Swedish pharmacies", says Christer Fåhraeus, CEO of EQL Pharma. "In order to get reimbursement for

SimCorp A/S – Share buyback program

Company Announcement no. 09/2021On February 10, 2021 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 10, 2021 to July 31, 2021. The following transactions have been executed under the program:          Date                 Number of shares

Storebrand Livsforsikring AS: Contemplating new green bond issue and tender offer

Storebrand Livsforsikring AS, rated A- by S&P, has mandated BNP Paribas, Danske Bank and J.P. Morgan as Joint Bookrunners, and J.P. Morgan as Sole Green Structuring Agent to the Issuer, to arrange a series of fixed income investor calls to present its newly established Green Bond Framework. A EUR 300m green 30.5NC10.5 year Tier 2 subordinated transaction will follow, subject to market conditions. The green bond is expected to be rated BBB by S&P and a Second Party Opinion has been made available by Sustainalytics. In conjunction with the contemplated new green bond issuance, Storebrand

STOREBRAND ASA: Contemplating new green bond issue and tender offer

Storebrand Livsforsikring AS, rated A- by S&P, has mandated BNP Paribas, Danske Bank and J.P. Morgan as Joint Bookrunners, and J.P. Morgan as Sole Green Structuring Agent to the Issuer, to arrange a series of fixed income investor calls to present its newly established Green Bond Framework. A EUR 300m green 30.5NC10.5 year Tier 2 subordinated transaction will follow, subject to market conditions. The green bond is expected to be rated BBB by S&P and a Second Party Opinion has been made available by Sustainalytics. In conjunction with the contemplated new green bond issuance, Storebrand

Adjustment of proposal on the election of auditors for the annual general meeting

Reference is made to the notice to the annual general meeting of Heimstaden AB (publ), published on 8 March 2021. Due to internal changes at Ernst & Young, an adjustment has been made to the proposal on election of auditors in item no. 15 of the agenda. After the adjustment, the board of directors proposes that authorised public accountant Jonas Svensson at Ernst & Young AB, is elected as one of Heimstaden’s auditors. Registered accounting firm Ernst & Young AB is still proposed to be re-elected as the second auditor with Peter von Knorring as auditor in charge. Heimstaden’s annual

Kallelse till extra bolagsstämma i Nilar International AB (publ) / Notice of extra general meeting in Nilar International AB (publ)

Aktieägarna i Nilar International AB, org. nr 556600-2977, ("Bolaget") kallas härmed till extra bolagsstämma måndagen den 19 april 2021 kl. 10.00 i Baker & McKenzie advokatbyrås lokaler på Vasagatan 7 i Stockholm. The shareholders of Nilar International AB, reg. no. 556600-2977, (the "Company"), are hereby convened to the extra general meeting to be held on Månday 19 April 2021, at 10.00 at Baker & McKenzie’s premises on Vasagatan 7 in Stockholm, Sweden.

Wärtsilä to deliver Cargo Handling and Fuel Supply systems for six very large LPG carrier vessels

Wärtsilä Corporation, Press release, 22 March 2021 at 11 AM EETThe technology group Wärtsilä has won the contract to supply the Cargo Handling  and Fuel Supply systems  for six new 93,000 m3 capacity Liquid Petroleum Gas (LPG) carrier vessels. The ships are being built at the Jiangnan Shipyard in China for Singapore-based Petredec. The order with Wärtsilä was placed in March 2021. These will be among the largest vessels of this type ever built. They will be fitted with Wärtsilä’s well-proven and highly efficient Cargo Handling system

Get Inspired selects Avensia as its partner

The Norwegian pure player Get Inspired, named e-business of the year in Norway for 2020, has selected Avensia as its partner in its bid to launch its next generation e-business. This collaboration covers both digital strategy and the technical implementation of the new digital platform.Getinspired.no, a leading e-business in sports and leisure wear for women in Norway, has selected Avensia, a leading global knowledge company within the field of modern digital commerce, to take the business to the next level. Avensia, together with Get inspired, will future-proof the entire digital

MUNTERS ANNUAL AND SUSTAINABILITY REPORT 2020

Munters Group AB´s (NASDAQ:MTRS) Annual and Sustainability Report 2020 has been published on www.munters.com in English and Swedish. The report can be downloaded here: https://www.munters.com/en/investor-relations/financial-reports/ The report has also been printed in a limited edition and can be ordered from info@munters.com.   This information is information that Munters Group AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 09:50 CET on March 22, 2021. Contact information Ann-Sofi Jönsson, Vice

Notice of Annual General Meeting in Swedish Stirling AB (publ)

The shareholders of Swedish Stirling AB (publ), Reg. No 556760-6602, are hereby invited to the Annual General Meeting on Friday, 23 April 2021.Information about measures due to the ongoing corona pandemic In the light of the ongoing corona pandemic and in order to minimize any risk of spreading of the corona virus, the Board of Directors has decided that the Annual General Meeting (the “AGM”) is to be held only through postal voting in accordance with temporary legislation. This means that the AGM will be conducted without the physical presence of shareholders, representatives or

Neste Corporation - Managers' Transactions, Vanacker (disposal)

Neste Corporation, Managers' Transactions, 22 March 2021 at 10.15 a.m. (EET)____________________________________________ Person subject to the notification requirementName: Vanacker, PeterPosition: Chief Executive OfficerIssuer: Neste OyjLEI: 5493009GY1X8GQ66AM14 Notification type: INITIAL NOTIFICATIONReference number: 5493009GY1X8GQ66AM14_20210322094644_2____________________________________________ Transaction date: 2021-03-19Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009013296Nature of the transaction: DISPOSAL Transaction details(1)

Everfuel – Company presentation

Herning, Denmark, 22 March 2021 – Everfuel A/S is today presenting at an investor seminar focused on hydrogen hosted by Nordea Markets. Please see the attached presentation. For additional information, please contact Jacob Krogsgaard, CEO, +45 2871 8945 About Everfuel | www.everfuel.com Everfuel is making green hydrogen for zero emission mobility commercially available across Europe, offering competitive all-inclusive hydrogen supply- and fueling solutions. We own and operate green hydrogen infrastructure and partner with vehicle OEMs to connect the entire hydrogen value

Prostate cancer screening with Stockholm3 reduces unnecessary biopsies and is cost-effective

STOCKHOLM, March 22, 2021. A3P Biomedical announced today that an independent and peer reviewed study showed health economic benefits using Stockholm3 versus PSA in a screening by invitation setting for prostate cancer. The results from the study demonstrated that Stockholm3 reduced unnecessary biopsies and was cost-effective compared to screening with the currently used PSA test.In previous peer-reviewed studies, e.g. the pivotal STHLM3 study on 58,000 men published in Lancet Oncology, the Stockholm3 test demonstrated significant health benefits compared to PSA (current standard of care)

Pihlajalinna has published the 2020 Annual Report, Remuneration Report and Corporate Governance Statement

Pihlajalinna Plc                  Stock exchange release                      22 March 2021 at 10:00 a.m. Pihlajalinna has published the 2020 Annual Report, Remuneration Report and Corporate Governance Statement Pihlajalinna’s Annual Report for 2020 has been published on the company’s website at the address investors.pihlajalinna.fi. The Annual Report contains the financial statements, Board of Director’s annual report, and auditor’s report. Additionally, Pihlajalinna has published a Renumeration Report, Corporate Governance Statement and Statement of non-financial information.

Elcowire introduces Low-carbon Copper

Elcowire is introducing Low-carbon Copper in parts of production carried out at the plants in Helsingborg, Sweden, and in Hettstedt, Germany. The new copper quality marks significant progress towards reducing the CO\2\ footprint. The resulting CO\2\ emissions are less than half of the global average (4.1 kg CO\2\/kg copper) quoted by the International Copper Association (ICA). The product comes from Boliden’s mines in northern Sweden and Finland and is the result of a substantial transformation due to electrification of various stages in the mining process. The new Low-carbon Copper has

Tokmanni capital markets day 2021: Tokmanni seeks to maintain its strong growth and announces its new financial targets

Tokmanni Group Corporation        Stock exchange release        22 March 2021 at 10.00 amTokmanni's revenue has continued to grow and profitability has continued to improve robustly for several years. Tokmanni's strategy has proven its effectiveness. The revenue growth target and a comparable 9 percent EBIT margin were already reached in 2020. “Tokmanni is updating its strategy for the years 2021 to 2025. It is a natural continuation of the company's strategy announced in 2018. We will continue our determined measures targeting strong growth and better profit. The growth target for

Regily completes oversubscribed private placement attracting top Nordic tech investors

Tech success Regily, founded by former product frontmen of Klarna, recently completed an oversubscribed private placement. The placement attracted top tier Nordic tech investors TIN Funds, Knutsson Holdings, Norron Funds and Erik Selin. This is the first time TIN Funds invests in an unlisted company. Erik Penser Bank handled the placement with a total sum of 20 million SEK.The purpose of the private placement is mainly to increase focus on sales and marketing activities and to expand to new verticals. Erik Penser Bank handled the placement where well known investors TIN Funds, Knutsson

New CEO and President of A Society

Per-Ola Malm, currently Vice President of A Society, will be the new President and CEO of A Society starting April 1, 2021.The A Society Group, headquartered in Malmö and which this year is estimated to have a turnover of 1.6 billion, is today represented by 16 offices around the world. Per-Ola Malm has been working in A Society for 14 years and has solid experience of the consulting industry in both sales and leading roles. When Thomas Goréus, current President and CEO, after 15 successful years chooses to move abroad and thus requests to leave his position, Per-Ola Malm will lead the

Invitation to a conference call and webcast in connection with Isofol receiving recommendation to complete the global Phase III AGENT study for market registration as planned with 440 patients

GOTHENBURG, Sweden, March 22, 2021 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) announced on 19 March 2021 that the independent Data Safety and Monitoring Board (iDSMB) has recommended continuation of the global Phase III AGENT study with 440 patients, in accordance with the study design for the drug candidate, arfolitixorin. In connection with this, Isofol invites investors, analysts and media to a conference call and webcast on March 22, 2021 at 14:00 (CET).The presentation will be held by Isofol's CEO Ulf Jungnelius in English and will

There are no items matching the current filter
There are no more items matching the current filter
Back to top